GlassScriptPhysician profile
Kushal Handa
NPI 1396762258
$3,589.67
in general payments reported to CMS, 2019-2025
16 companies · $29.84 in 2025
The $29.84 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,156 · 2020: $83.26 · 2021: $182 · 2022: $663 · 2023: $267 · 2024: $208 · 2025: $29.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,239.67 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $284.85 | 2022-2024 | Leqvio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $182.02 | 2021 | |
| Boston Scientific Corporation | $134.73 | 2022 | |
| Glaxosmithkline, LLC. | $128.13 | 2023 | |
| Abbott Laboratories | $126.47 | 2024 | Mitraclip |
| Janssen Pharmaceuticals, INC | $87.49 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $87.36 | 2022 | |
| Cardiva Medical, INC. | $85.70 | 2022 | |
| Medtronic, INC. | $80.79 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $35.75 | 2023-2024 | Camzyos |
| Heartflow, INC. | $29.84 | 2025 | |
| Philips North America LLC | $29.56 | 2024 | (Cm9) Amb Mon & Diag Und |
| Amgen INC. | $22.34 | 2023 | Repatha |
| Terumo Medical Corporation | $19.99 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $14.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kushal Handa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.